ALRN - Aileron Therapeutics GAAP EPS of -$0.09 August, 15 2022 05:29 PM Aileron Therapeutics Inc. Aileron Therapeutics press release ( NASDAQ: ALRN ): Q2 GAAP EPS of -$0.09. Cash, cash equivalents, and investments on June 30, 2022, were $32.4 million. For further details see: Aileron Therapeutics GAAP EPS of -$0.09